How to buy Nyrada shares | A$0.22

Nyrada Inc is a biotechnology business based in Australia. Nyrada shares (NYR) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $0.22 – an increase of 7.32% over the previous week. Nyrada has a trailing 12-month revenue of around $1.1 million.

How to buy shares in Nyrada

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for Nyrada. Find the share by name or ticker symbol: NYR. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Nyrada reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $0.22, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of Nyrada. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

How has coronavirus impacted Nyrada's share price?

Since the stock market crash in March caused by coronavirus, Nyrada's share price has had significant positive movement.

Its last market close was $0.22, which is 6.82% up on its pre-crash value of $0.205 and 100.00% up on the lowest point reached during the March crash when the shares fell as low as $0.11.

If you had bought $1,000 worth of Nyrada shares at the start of February 2020, those shares would have been worth $550.00 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,100.00.

Nyrada share price

Use our graph to track the performance of NYR stocks over time.

Nyrada shares at a glance

• Key figures

Information last updated 2020-10-20.

Latest market close	AUDA$0.22
52-week range	AUDA$0.11 - AUDA$0.305
50-day moving average	AUDA$0.2054
200-day moving average	AUDA$0.1871
Target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	N/A

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Nyrada stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Nyrada Inc by TradingView

Nyrada price performance over time

Historical closes compared with the close of A$0.22 on 2020-10-22

1 week (2020-10-19)	10.00%
1 month (2020-09-25)	2.33%
3 months (2020-07-24)	18.92%
6 months (2020-04-24)	25.71%

1 year (2019-10-22)	N/A
2 years (2018-10-22)	N/A
3 years (2017-10-22)	N/A
5 years (2015-10-22)	N/A

Nyrada financials

Revenue TTM	$1.1 million
Gross profit TTM	$-274,585
Return on assets TTM	-95.02%
Return on equity TTM	-2018.29%
Profit margin	0%
Book value	0.051
Market capitalisation	$23.5 million

TTM: trailing 12 months

Nyrada share dividends

We're not expecting Nyrada to pay a dividend over the next 12 months.

Nyrada overview

Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular, neurodegenerative, and chronic inflammatory diseases. Its products in drug development stage include PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury; a drug to treat pain associated with peripheral nerve damage; and a drug to treat autoimmune diseases, such as psoriasis. The company was founded in 2017 and is based in Gordon, Australia.

Frequently asked questions

• What percentage of Nyrada is owned by insiders?

  Currently 57.197% of Nyrada shares are held by insiders.

• When does the fiscal year end for Nyrada?

  Nyrada's fiscal year ends in June.

• Where is Nyrada based?

  Nyrada's address is: 828 Pacific Highway, Gordon, NSW, Australia, 2072